US/UK/Canada

Share

Contacts

  • Arjo AB
    Hans Michelsensgatan 10 211 20 Malmö SWEDEN
    +46 10 335 4500
    http://www.arjo.com
  • Maria Nilsson

    EVP Communication & Public Relations


    +46 10 335 4866
    +46 734 244 515
  • Erik Roslund

    Investor Relations & Corporate Communications Manager


    +46 103354875
    +46 768996303
    • Pick a time period -
    Tags ( Active)

    Arjo’s interim report January-June 2026

    “We grew by 4.7% organically in the quarter, driven by high demand for our products and solutions. We are also now taking important steps to enhance our focus, efficiency, and profitability – and to create better conditions for long-term value creation,” says Andréas Elgaard, President & CEO of Arjo.   April-June 2026 in brief · Net sales increased to SEK 2,759 M (2,678). Net sales grew organically by 4.7%. · The gross margin was 42.1% (43.4). · Adjusted EBITDA increased to SEK 482 M (475). · Adjusted operating profit increased to SEK 211 M (208). · Profit after

    Arjo announces date for 2026 Q2 and conference call

    Arjo will issue its interim report for Q2 on Tuesday July 14 at 07:00 CEST, followed by a conference call at 08:00, hosted by Andréas Elgaard, President and CEO, and Christofer Carlsson, CFO. Fund managers, analysts and media are invited to participate in a conference call and presentation of the report via the following link  and a recorded version of the conference is accessible for three years here . Those who wish to ask questions verbally in the teleconference will need to register via

    Arjo’s interim report January-June 2025

    ”We are growing in line with our target with double-digit growth in the US, while further strengthening our order book. In parallel, our focused cost efficiency efforts are generating results, and adjusted for currency effects and US tariffs, underlying profitability for the quarter trended positively. We now look forward to a strong net sales development in the second half of 2025,” says Niclas Sjöswärd, Interim President & CEO of Arjo.   April-June 2025 in brief · Net sales amounted to SEK 2,678 M (2,810). Net sales grew organically by 3.0%. · The gross margin was 43.4% (43.

    Arjo announces date for 2025 Q2 and conference call

    Arjo will issue its interim report for Q2 on Friday July 11 at 07:00 CEST, followed by a conference call at 08:00 CEST, hosted by Niclas Sjöswärd, interim President and CEO, and Christofer Carlsson, interim CFO. Fund managers, analysts and media are invited to participate in a conference call and presentation of the report via the following link  and a recorded version of the conference is accessible for three years here . Those who wish to ask questions verbally in the teleconference will

    Arjo’s interim report January-June 2024

    ”Our journey towards long-term profitability improvement continues and we deliver yet another quarter of growth and increased profitability. The positive development in rental and service continued globally and we navigate the market in a good way, despite short-term challenges. There is a major need for investments in healthcare and overall we see healthy growth opportunities moving forward,” says Joacim Lindoff, President and CEO of Arjo. April-June 2024 in brief · Net sales increased to SEK 2,810 M (2,686). Net sales grew organically by 3.7%. · Adjusted EBITDA increased to SEK

    Arjo announces date for 2024 Q2 report and conference call

    Arjo will issue its interim report for Q2 on Friday July 12 at 07:00 CEST, followed by a conference call at 08:00 CEST, hosted by Joacim Lindoff, President & CEO, and Niclas Sjöswärd, CFO. Fund managers, analysts and media are invited to participate in a conference call and presentation of the report via the following link . Those who wish to ask questions verbally in the teleconference will need to register via the link below. A phone number and a conference ID will be provided after registration in order to access the conference.

    Arjo’s interim report January-June 2023

    ”The recovery following a turbulent 2022 continues and we grew 5% organically with improved profitability and strong cash flow. Demand was healthy in many markets and despite continuing challenging market conditions in the US, we expect to deliver organic growth for the full-year within our target interval of 3–5%,” says Joacim Lindoff, President and CEO of Arjo.  April-June 2023 in brief · Net sales increased to SEK 2,686 M (2,404).Net sales grew organically by 5.0%. · Adjusted EBITDA rose to SEK 490 M (430). · Adjusted operating profit increased to SEK 206 M (165). ·

    Arjo announces date of 2023 Q2 report and conference call

    Arjo will issue its interim report for Q2 2023 on Friday July 14 at 07:00 CEST, followed by a conference call at 08:00 CEST, hosted by Joacim Lindoff, President & CEO. Fund managers, analysts and media are invited to participate in a conference call and presentation of the report via the following link: https://ir.financialhearings.com/arjo-q2-2023 Those who wish to ask questions verbally via the teleconference will need to register via the link below. A phone number and a conference ID will be provided after registration in order to access the conference. Link to registration:

    Arjo interim report January-June 2022

    “Market demand remains healthy and the order book for capital equipment continues to be significantly above last year’s levels. Performance in the quarter is held back by short-term challenges due to postponed sales in patient handling, significantly lower critical care rental volumes in the US compared with last year, and continued supply chain disruptions,” says Joacim Lindoff, President & CEO of Arjo. “We have a continued positive momentum within many areas and our underlying business continues to develop well. We estimate that growth will gradually increase in the year’s final two

    Arjo announces date for interim report January-June 2022 and conference call

    Arjo will issue its interim report for January-June 2022 on Thursday July 14 at 07:00 CEST, followed by a conference call at 08:00 CEST, hosted by Joacim Lindoff, President & CEO, and Daniel Fäldt, CFO. We invite fund managers, analysts and the media to participate in the conference call. Please see details below to join the conference.  Swedish dial-in number: +46 8 505 163 86USA: +1 412 317 6300UK: +44 20 319 84884Pin code: 4127122# (to be used for all numbers) During the telephone conference, a presentation will be held. To access the presentation, please use this link:

    Arjo interim report January-June 2021

    ”We close another strong quarter and grow organically by 4,0%, supported by a solid order intake. We successfully navigate the Covid-19 challenges and see a continued recovery within profitable categories like patient handling, service and DVT. Our profitability continues to improve and we report an adjusted EBITDA-margin exceeding 23% for the first time,” says Joacim Lindoff, President & CEO. “The implementation of our long-term strategy continues with full force, at the same time as we are delivering on our short-term targets. Our newly launched SEM scanner is generating high interest

    Arjo announces date of 2021 Q2 report and conference call

    Arjo will issue its Q2 report for 2021 on Thursday July 15 at 07:00 CET, followed by a conference call at 08:00 CET, hosted by Joacim Lindoff, President & CEO, and Daniel Fäldt, CFO. We invite fund managers, analysts and the media to participate in the conference call. Please see details below to join the conference.  Swedish dial-in number: +46 8 505 583 59USA: +1 646 722 4956UK: +44 333 300 9265 During the telephone conference, a presentation will be held. To access the presentation, please use this link: https://tv.streamfabriken.com/arjo-q2-2021 Alternatively, use the

    Arjo interim report January-June 2020

    ”During the quarter, we have continued the important job of supporting healthcare through these challenging times. We grew organically by 2.2%, which should be seen in relation to a strong comparative quarter of 2019. At the same time, the adjusted operating profit (EBIT) increased by almost 50%. We have seen continued high demand within our US rental operations, as well as within medical beds and therapeutic mattresses,” says Joacim Lindoff, President & CEO. “We have a strong financial position and improved cash flow that provides a solid foundation despite the turbulence around the corona

    Arjo interim report January-June 2019

    “We deliver another strong quarter with a good sales development across several markets and report an organic growth of 6.5%. Our strongest growth was in North America, especially in the US, where our positive trend continues,” says Joacim Lindoff, President & CEO. “With this solid start to the year together with a continued high activity level, we now raise the outlook for our full-year organic net sales growth to be in the upper part of the 2-4% interval.” April-June 2019 in brief · Net sales increased by 10.7% to SEK 2,197 M (1,986). Net sales grew organically by 6.5%. ·

    Arjo announces date of 2019 Q2 report and conference call

    Arjo will issue its Q2 report for 2019 on Thursday July 18 at 07:30 CET, followed by a conference call at 08:00 CET, hosted by Joacim Lindoff, President & CEO, and Jonas Lindqvist, CFO. The previously communicated date of July 19 has been altered for practical reasons. We invite fund managers, analysts and the media to participate in the conference call. Please see details below to join the conference. Swedish dial-in number: +46 (0)8 5033 6574UK: +44 (0)330 336 9105USA: +1 323-794-2093Participant passcode: 9808789 During the telephone conference, a presentation will be held.

    Arjo announces date of 2018 Q2 report and conference call

    Arjo will issue its Q2 report for 2018 on Thursday July 19th at 08:00 CET, followed by a conference call at 09:00 CET, hosted by Joacim Lindoff, President & CEO, and Jonas Lindqvist, CFO. We invite fund managers, analysts and the media to participate in the conference call. Please see details below to join the conference: Swedish dial-in number: +46 (0)8 5065 3942UK dial-in number:        +44 (0)330 336 9411US dial-in number:        +1 323-994-2093Participant passcode:    9801891 During the telephone conference, a presentation will be held. To access the presentation, please

    There are no items matching the current filter
    There are no more items matching the current filter
    Back to top

    Subscribe

    Media